🇺🇸 FDA
Pipeline program

Valbenazine

NBI-98854-TD4027

Approved small_molecule active

Quick answer

Valbenazine for Schizophrenia is a Approved program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 3 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Schizophrenia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials